Morgan Stanley raised its price target for Torchmark Corp. (NYSE:TMK) to from and maintained its underweight rating on the stock. Torchmark Corporation is an insurance and financial services holding company. The Company’s subsidiaries offer life and health insurance, and annuities. Life products include traditional and interest sensitive whole life insurance as well as term life insurance. Health products include Medicare supplement, cancer, accident, long-term care, and limited hospital and surgical coverages. Torchmarkhas a potential upside of 3.1% based on a current price of .27 and an average consensus analyst price target of .17. Torchmark is currently above its 50-day moving average (MA) of .78 and above its 200-day of .55. In the last five trading sessions, the 50-day MA has climbed 1.4% while the 200-day MA has risen 0.68%.
Video Rating: 5 / 5

Popular Posts:

• American National Life Insurance Company of New York Announces A.M. Best Rating
• Pan-American Life Insurance Company and Affiliates’ Financial Strength Rating Upgraded by A.M. Best
• Fossil Morgan Traveler – Sienna
• A.M. Best Co. Awards A++ Superior Rating to Auto-Owners Insurance Company
• State Farm Agent Morgan E. Faulkenberry in Columbia SC – Car Home Life Insurance

Related Posts:

• Morgan Stanley tops H1 global IPO league table
• Fossil Morgan Traveler – Medium Brown
• Fossil Morgan Traveler – Olive
• Fossil Morgan Traveler – Sienna
• Fossil Morgan Traveler – Chocolate